Back to search

Luna Therapeutics Limited

12823998

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk

No risk factors detected.

Details

LONDON BIOSCIENCE INNOVATION CENTRE, LONDON, NW1 0NH
Incorporated 19/08/2020

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Prof Richard Michael Day

director · Since 19/08/2020

UNIVERSITY LECTURER

BRITISH · ENGLAND · Age 52

Dr Stephen Andrew France

director · Since 19/08/2020

BUSINESS CONSULTANT

BRITISH · ENGLAND · Age 52

Also on 1 other board

Persons with Significant Control

Prof Richard Michael Day

75–100% shares

British · England · Age 52

85, Great Portland Street, London, W1W 7LT

Notified 19/08/2020

CompanyRankvs 1662+ SIC 72110 peers
49

Financial strength85th percentile among SIC peers · 21/25
Employees47th percentile among SIC peers · 7/15
LiquidityNo balance sheet data · 0/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/08/2025

Net Worth

£252k

Balance sheet strength

Cash

£184k

Cash in the bank

Net Current Assets

£189k

Working capital

Current Assets

Current Liabilities

-£5k

Fixed Assets

£64k

1avg. employees

Tax at Year End

VAT-£2k

Balance Sheet

Assets less current liabilities£253k
Prepared with Taxfiler

EstimatesDerived

YearCurrent RatioImplied Profit
2025-£45k
2024238.28-£67k
2023449.49+£2k
202276.24+£240k
202119.60

Derived from filed accounts. Not audited figures.